NVRO Nevro Corp. Stock Quote

NVRO [NYSE]

Index	-	P/E	-	EPS (ttm)	-2.72	Insider Own	1.40%	Shs Outstand	34.36M	Perf Week	5.05%
Market Cap	6.15B	Forward P/E	-	EPS next Y	-1.61	Insider Trans	-24.63%	Shs Float	32.92M	Perf Month	2.49%
Income	-89.70M	PEG	-	EPS next Q	-0.34	Inst Own	-	Short Float	7.93%	Perf Quarter	16.53%
Sales	366.70M	P/S	16.77	EPS this Y	-105.60%	Inst Trans	0.12%	Short Ratio	7.67	Perf Half Y	36.12%
Book/sh	11.05	P/B	16.08	EPS next Y	37.60%	ROA	-14.60%	Target Price	189.75	Perf Year	46.85%
Cash/sh	16.55	P/C	10.74	EPS next 5Y	25.00%	ROE	-30.30%	52W Range	65.05 - 188.14	Perf YTD	2.65%
Dividend	-	P/FCF	-	EPS past 5Y	-22.10%	ROI	-26.00%	52W High	-5.55%	Beta	1.00
Dividend %	-	Quick Ratio	2.70	Sales past 5Y	64.30%	Gross Margin	69.50%	52W Low	173.16%	ATR	7.99
Employees	853	Current Ratio	3.10	Sales Q/Q	8.30%	Oper. Margin	-20.10%	RSI (14)	57.38	Volatility	5.17% 4.58%
Optionable	Yes	Debt/Eq	0.81	EPS Q/Q	49.60%	Profit Margin	-24.50%	Rel Volume	1.91	Prev Close	175.19
Shortable	Yes	LT Debt/Eq	0.37	Earnings	Nov 05 AMC	Payout	-	Avg Volume	340.41K	Price	177.69
Recom	1.70	SMA20	1.57%	SMA50	4.87%	SMA200	26.90%	Volume	651,726	Change	1.43%

Oct-23-20

Initiated

Guggenheim

Buy

$190

Sep-02-20

Initiated

Robert W. Baird

Outperform

$160

Jun-08-20

Upgrade

UBS

Sell → Neutral

$100 → $132

Mar-05-20

Initiated

Citigroup

Buy

$160

Feb-26-20

Upgrade

Canaccord Genuity

Hold → Buy

$153

Jan-08-20

Initiated

SunTrust

Buy

$132

Jan-06-20

Downgrade

Oppenheimer

Outperform → Perform

Nov-07-19

Upgrade

Oppenheimer

Perform → Outperform

$106

Oct-22-19

Initiated

Oppenheimer

Perform

Mar-20-19

Upgrade

Wells Fargo

Market Perform → Outperform

$75

Mar-20-19

Upgrade

BofA/Merrill

Neutral → Buy

$50 → $70

Nov-28-18

Initiated

UBS

Sell

Nov-07-18

Downgrade

BofA/Merrill

Buy → Neutral

Nov-06-18

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Nov-06-18

Downgrade

JP Morgan

Overweight → Neutral

Oct-19-18

Downgrade

Goldman

Neutral → Sell

Jul-02-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

May-08-18

Reiterated

Canaccord Genuity

Buy

$110 → $102

May-08-18

Downgrade

Wells Fargo

Outperform → Market Perform

May-08-18

Downgrade

Northland Capital

Outperform → Market Perform

Jan-19-21 11:24AM	Brain, Spine Stimulation Devices Are a Post-Pandemic Winner, Says Raymond James Barrons.com
07:00AM	Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy PR Newswire
Jan-14-21 07:00AM	Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting PR Newswire
Jan-12-21 11:41AM	Nevro (NVRO) Posts Weak Preliminary Q4 and 2020 Revenues Zacks
Jan-11-21 02:18PM	Nevro Earns Relative Strength Rating Upgrade To 71 Investor's Business Daily
07:00AM	Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue PR Newswire
Dec-29-20 08:09AM	The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga
07:38AM	Nevro's (NVRO) FDA Submission to Treat Patients With PDN Zacks
Dec-28-20 04:08PM	Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy PR Newswire
Dec-22-20 04:05PM	Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference PR Newswire
09:44AM	Is NVRO A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-16-20 02:40AM	Nevro Corp.'s (NYSE:NVRO) Intrinsic Value Is Potentially 49% Above Its Share Price Simply Wall St.
Dec-15-20 04:05PM	Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 PR Newswire +5.03%
Dec-14-20 06:54PM	Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California PR Newswire
04:30PM	Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific PR Newswire
Dec-09-20 11:39AM	Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks
Dec-05-20 11:32AM	Why Is Nevro (NVRO) Up 1.7% Since Last Earnings Report? Zacks
Dec-03-20 07:00AM	Nevro Announces Director Appointment PR Newswire
Nov-30-20 07:00AM	Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications PR Newswire -5.72%
Nov-24-20 07:00AM	Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th PR Newswire
Nov-17-20 04:02PM	Nevro Announces Abstract Presentations for PDN and NSRBP Trials Have Been Accepted for the Late Breaking Trials Plenary Session at NANS 2021 Conference PR Newswire
Nov-10-20 09:52AM	Was The Smart Money Right About Crowding Into Nevro Corp (NVRO)? Insider Monkey
Nov-09-20 08:09AM	Nevro (NVRO) Rallies 1.3% Despite Delivering Loss in Q3 Zacks +6.63%
06:02AM	Nevro Corp. (NYSE:NVRO) Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Nov-06-20 10:31PM	Nevro Corp (NVRO) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 07:20PM	Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:02PM	Nevro Announces Third Quarter 2020 Financial Results PR Newswire
01:24PM	Nevro Corp. to Host Earnings Call ACCESSWIRE
11:07AM	Health Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt? Simply Wall St.
Oct-29-20 12:35PM	Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-22-20 04:05PM	Nevro to Report Third Quarter 2020 Financial Results PR Newswire
Oct-14-20 06:15AM	Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks
Sep-23-20 06:43PM	How a Winning Fund Gets Big Returns From Smaller Stocks Barrons.com
Sep-21-20 01:25PM	Can You Imagine How Jubilant Nevro's (NYSE:NVRO) Shareholders Feel About Its 218% Share Price Gain? Simply Wall St.
Sep-17-20 09:30AM	Nevro Bolsters Growth Prospects With New Manufacturing Plan Zacks
Sep-14-20 07:00AM	Nevro Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth PR Newswire
Sep-10-20 10:11AM	Hedge Funds Have Never Been This Bullish On Nevro Corp (NVRO) Insider Monkey
Sep-08-20 06:51AM	Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks
Sep-04-20 11:31AM	Nevro (NVRO) Down 2.3% Since Last Earnings Report: Can It Rebound? Zacks
Sep-01-20 07:00AM	Nevro to Present at Upcoming Conferences PR Newswire
Aug-26-20 01:27PM	Nevro Earns Relative Strength Rating Upgrade; Hits Key Benchmark Investor's Business Daily
Aug-07-20 07:20AM	Nevro (NVRO) Q2 Loss Narrower than Expected, Revenues Beat Zacks
07:00AM	Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference PR Newswire
Aug-06-20 01:24PM	Is Nevro Corp. (NYSE:NVRO) Potentially Undervalued? Simply Wall St.
Aug-05-20 05:45PM	Nevro (NVRO) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:10PM	Nevro Announces Second Quarter 2020 Financial Results PR Newswire
Jul-31-20 10:54AM	Why Nevro Corp (NVRO) Stock is a Compelling Investment Case Insider Monkey
Jul-29-20 12:33PM	Nevro (NVRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Jul-20-20 07:00AM	Nevro to Report Second Quarter 2020 Financial Results PR Newswire
Jul-13-20 04:17PM	Did Hedge Funds Make The Right Call On Nevro Corp (NVRO) ? Insider Monkey
Jul-10-20 08:46AM	Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks
Jun-13-20 08:59AM	Edited Transcript of NVRO earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-08-20 12:33PM	Edited Transcript of NVRO earnings conference call or presentation 25-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Jun-05-20 10:31AM	Most Hedge Funds Sticking With Nevro Corp (NVRO) Insider Monkey
Jun-04-20 11:31AM	Why Is Nevro (NVRO) Up 7.1% Since Last Earnings Report? Zacks
07:00AM	Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer PR Newswire
May-27-20 06:24AM	Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks
May-18-20 06:59AM	Nevro's (NVRO) Senza Omnia SCS System Gets CE Mark Approval Zacks
May-14-20 07:00AM	Nevro Announces CE Mark Approval of Senza® Omnia Spinal Cord Stimulation System to Treat Chronic Pain PR Newswire
May-07-20 09:14AM	Nevro (NVRO) Earnings and Revenues Beat Estimates in Q1 Zacks
May-06-20 08:04AM	Nevro Corp (NVRO) Q1 2020 Earnings Call Transcript Motley Fool
May-05-20 07:25PM	Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates Zacks +5.24%
Apr-28-20 12:33PM	Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-21-20 07:00AM	Nevro to Report First Quarter 2020 Financial Results PR Newswire
Apr-09-20 12:42PM	Nevro Announces Federal Circuit Rules in its Favor and Upholds the Validity of Nevro's Patent Claims In Its Litigation Against Boston Scientific PR Newswire
Apr-08-20 10:17PM	Edited Transcript of NVRO earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents +8.38%
Apr-03-20 04:44PM	Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes PR Newswire
08:30AM	Nevro (NVRO) Looks Good: Stock Adds 6.5% in Session Zacks
Apr-02-20 08:00AM	Nevro Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes PR Newswire +6.51%
07:57AM	The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation Benzinga
Apr-01-20 04:40PM	Nevro Announces Proposed Public Offering of Common Stock and Convertible Senior Notes PR Newswire -10.53%
04:07PM	Nevro Provides First Quarter and FY2020 Update PR Newswire
Mar-27-20 03:50PM	Hedge Funds Have Never Been More Bullish On Nevro Corp (NVRO) Insider Monkey -5.59%
Mar-26-20 11:30AM	Why Is Nevro (NVRO) Down 34.3% Since Last Earnings Report? Zacks
Mar-22-20 11:03AM	Three stocks that are part of the solution to the coronavirus crisis MarketWatch
Mar-11-20 08:50AM	Nevro (NVRO): Strong Industry, Solid Earnings Estimate Revisions Zacks -7.82%
Feb-28-20 08:45AM	Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S. PR Newswire
08:45AM	Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction PR Newswire
Feb-27-20 11:12AM	Nevro Corp. Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Feb-26-20 09:21AM	Nevro (NVRO) Q4 Loss Narrower Than Expected, Revenues Up Y/Y Zacks
Feb-25-20 05:35PM	Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:10PM	Nevro Reports Fourth Quarter and Full Year 2019 Financial Results PR Newswire
Feb-24-20 08:35AM	Why Earnings Season Could Be Great for Nevro (NVRO) Zacks
Feb-21-20 10:20AM	MEDNAX (MD) Q4 Earnings and Revenues Surpass Estimates Zacks
Feb-13-20 08:16AM	3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Feb-10-20 09:47AM	Can Pharmacy Services Growth Aid CVS Health (CVS) Q4 Earnings? Zacks
08:26AM	DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
07:54AM	Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings Zacks
Feb-07-20 10:52AM	What's in the Offing for LabCorp's (LH) Earnings in Q4? Zacks
Feb-04-20 09:16AM	Here's Why You Should Hold on to Nevro (NVRO) Stock for Now Zacks
Jan-22-20 07:00AM	Nevro to Present New Clinical Evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting PR Newswire
Jan-20-20 10:07AM	Need To Know: Nevro Corp. (NYSE:NVRO) Insiders Have Been Buying Shares Simply Wall St.
07:00AM	Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality PR Newswire
Jan-16-20 10:14AM	Nevro (NVRO) Gains Ground on Solid Preliminary Q4 Results Zacks
Jan-14-20 07:00AM	Nevro Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue PR Newswire
Jan-10-20 07:00AM	Nevro to Host Investor Briefing at North American Neuromodulation Society (NANS) 2020 Conference PR Newswire
Dec-31-19 06:37AM	Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar? Zacks
Dec-26-19 10:06AM	Nevro (NVRO) Hits New 52-Week High: What's Driving the Stock? Zacks
Dec-20-19 03:28PM	Did Hedge Funds Drop The Ball On Nevro Corp (NVRO) ? Insider Monkey
Dec-19-19 07:00AM	Nevro to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pellegrini Niamh Louise	Chief Commercial Officer	Jan 11	Option Exercise	64.95	750	48,713	31,078	Jan 13 04:18 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Jan 11	Sale	169.80	750	127,350	30,328	Jan 13 04:18 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Dec 10	Option Exercise	64.95	750	48,713	31,078	Dec 14 04:38 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Dec 10	Sale	161.21	750	120,910	30,328	Dec 14 04:38 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Nov 10	Option Exercise	64.95	750	48,713	31,078	Nov 12 05:34 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Nov 10	Sale	170.75	750	128,063	30,328	Nov 12 05:34 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Oct 22	Sale	165.00	1,817	299,805	30,328	Oct 26 05:11 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Oct 19	Sale	155.00	1,000	155,000	32,145	Oct 21 04:15 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Oct 13	Option Exercise	64.95	750	48,713	33,895	Oct 13 06:16 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Oct 13	Sale	151.47	750	113,603	33,145	Oct 13 06:16 PM
DEMANE MICHAEL F	Director	Oct 12	Sale	151.21	903	136,543	236,207	Oct 13 04:35 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Oct 09	Sale	150.00	1,000	150,000	33,145	Oct 13 06:16 PM
DEMANE MICHAEL F	Director	Oct 09	Sale	150.31	20,529	3,085,745	237,110	Oct 13 04:35 PM
DEMANE MICHAEL F	Director	Sep 16	Sale	146.56	16,028	2,349,041	257,440	Sep 17 05:36 PM
DEMANE MICHAEL F	Director	Sep 15	Sale	145.27	2,000	290,546	273,468	Sep 17 05:36 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Sep 10	Option Exercise	64.95	750	48,713	34,895	Sep 14 04:06 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Sep 10	Sale	139.14	750	104,355	34,145	Sep 14 04:06 PM
DEMANE MICHAEL F	Director	Sep 02	Sale	145.25	3,400	493,864	275,468	Sep 04 04:14 PM
DEMANE MICHAEL F	Director	Aug 27	Sale	141.01	18,900	2,665,004	278,868	Aug 31 07:15 PM
DEMANE MICHAEL F	Director	Aug 13	Sale	140.05	300	42,016	347,768	Aug 17 04:41 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Aug 10	Option Exercise	64.95	750	48,713	34,895	Aug 10 06:55 PM
Pellegrini Niamh Louise	Chief Commercial Officer	Aug 10	Sale	140.11	750	105,083	34,145	Aug 10 06:55 PM
DEMANE MICHAEL F	Director	Aug 10	Sale	135.63	4,500	610,353	38,054	Aug 12 04:32 PM
DEMANE MICHAEL F	Director	Aug 10	Sale	135.68	83,440	11,321,141	348,068	Aug 12 04:32 PM
McCormick Shawn	Director	May 21	Sale	126.50	1,020	129,030	7,772	May 26 02:31 PM
Schmitz Patrick	Vice President, Operations	Feb 28	Option Exercise	66.75	42,884	2,862,581	61,542	Mar 03 02:49 PM
Galligan Andrew H	Chief Financial Officer	Feb 28	Option Exercise	3.60	8,000	28,800	61,490	Mar 03 02:48 PM
Schmitz Patrick	Vice President, Operations	Feb 28	Sale	128.78	42,884	5,522,574	18,658	Mar 03 02:49 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience